NOT AN OFFER TO INVEST. RED HERRING DISCLOSURE AVAILABLE ON REQUEST. PROFESSIONAL INVESTORS ONLY.

October 2022

REPORT. JAMA. 10 OCT 2022. LONG COVID symptom clusters 3 months after symptomatic SARS-CoV-2 infection was 6.2%, including 3.7% for ongoing respiratory problems, 3.2% for persistent fatigue with bodily pain or mood swings, and 2.2% for cognitive problems after adjusting for health status before COVID-19.

By |October 10, 2022|Categories: Blog Posts|

"Long COVID symptom clusters 3 months after symptomatic SARS-CoV-2 infection [...]

Comments Off on REPORT. JAMA. 10 OCT 2022. LONG COVID symptom clusters 3 months after symptomatic SARS-CoV-2 infection was 6.2%, including 3.7% for ongoing respiratory problems, 3.2% for persistent fatigue with bodily pain or mood swings, and 2.2% for cognitive problems after adjusting for health status before COVID-19.

COVID-19 VACCINE DATA. The most successful vaccination program in history. 12.7+ Billion Shots. 09 OCT 2022. BLOOMBERG.

By |October 9, 2022|Categories: Blog Posts|

More Than 12.7 Billion Shots Given: Covid-19 Tracker In the [...]

Comments Off on COVID-19 VACCINE DATA. The most successful vaccination program in history. 12.7+ Billion Shots. 09 OCT 2022. BLOOMBERG.

September 2022

EDITORIAL. Time for mRNA vaccine equality across the globe to save more lives. by Peter A. Jensen, CEO & Chairman, Normax

By |September 8, 2022|Categories: Blog Posts|

EDITORIAL. European Pharmaceutical Manufacturer - 8 September 2022 Peter [...]

Comments Off on EDITORIAL. Time for mRNA vaccine equality across the globe to save more lives. by Peter A. Jensen, CEO & Chairman, Normax
By |2023-02-09T13:57:54+00:00February 9, 2023|Uncategorized|Comments Off on
Go to Top